Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 2 years
- Director since
- 2024
2 years of board service in total across 1 board, counting each seat separately. Longest: Heron Therapeutics Inc., 2 years.
Heron Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 12, 2026 | Liquidia Corporation | Open-market sale | −18,938 | $28.48 | $539,354 |
| Oct 9, 2026 | Liquidia Corporation | Option exercise | +5,828 | — | — |
| Oct 9, 2026 | Liquidia Corporation | Option exercise | +7,049 | — | — |
| Jul 13, 2026 | Liquidia Corporation | Open-market sale | −1,453 | $71.39 | $103,730 |
| Jul 13, 2026 | Liquidia Corporation | Open-market sale | −18,977 | $71.52 | $1,357,235 |
| Jul 10, 2026 | Liquidia Corporation | Option exercise | +5,829 | — | — |
| Jul 10, 2026 | Liquidia Corporation | Option exercise | +7,050 | — | — |
| Apr 15, 2026 | Liquidia Corporation | Open-market sale | −9,044 | $40.14 | $363,026 |
| Apr 15, 2026 | Liquidia Corporation | Option exercise | +86,971 | $2.79 | $242,649 |
| Apr 15, 2026 | Liquidia Corporation | Open-market sale | −86,971 | $40.14 | $3,491,016 |
| Apr 15, 2026 | Liquidia Corporation | Open-market sale | −43,375 | $40.14 | $1,741,073 |
| Apr 14, 2026 | Liquidia Corporation | Option exercise | +3,000 | $2.79 | $8,370 |
| Apr 14, 2026 | Liquidia Corporation | Open-market sale | −3,000 | $40.00 | $120,000 |
| Apr 13, 2026 | Liquidia Corporation | Open-market sale | −18,958 | $38.37 | $727,418 |
| Apr 10, 2026 | Liquidia Corporation | Option exercise | +23,821 | $2.79 | $66,461 |
Questions about Michael Kaseta
What boards is Michael Kaseta on?
Michael Kaseta sits on the board of Heron Therapeutics Inc.
How long has Michael Kaseta served on boards?
Our records show at least 2 years of board service across 1 board, the earliest from 2024.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.